• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤药物及其分析:综述

Antineoplastic drugs and their analysis: a state of the art review.

机构信息

Pharmacy, Geneva University Hospitals (HUG), Geneva, Switzerland.

School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.

出版信息

Analyst. 2017 Jul 7;142(13):2273-2321. doi: 10.1039/c7an00367f. Epub 2017 May 31.

DOI:10.1039/c7an00367f
PMID:28560370
Abstract

The number of patients suffering from cancer is constantly increasing and, consequently, the number of different chemotherapy treatments administered is increasing. Given the high reactivity and toxicity of antineoplastic drugs, analytical methods are required in all pharmaceutical fields, from drug development to their elimination in wastewater; including formulation quality control, environment and human exposure and therapeutic drug monitoring. The aim of this paper is to provide an overview of the analytical methods available for the determination of antineoplastic drugs in different matrices such as pharmaceutical formulations, biological and environmental samples. The applicability and performance of the reported methods will be critically discussed, with focus on the most commonly used antineoplastic drugs. Only conventional compounds and small molecules for targeted therapy will be considered in the present review.

摘要

癌症患者的数量在不断增加,因此接受的化疗治疗种类也在增加。鉴于抗肿瘤药物的高反应性和高毒性,从药物开发到在废水中的消除,所有药物领域都需要分析方法;包括制剂质量控制、环境和人体暴露以及治疗药物监测。本文旨在综述不同基质中(如药物制剂、生物和环境样品)测定抗肿瘤药物的分析方法。将对报道的方法的适用性和性能进行批判性讨论,重点关注最常用的抗肿瘤药物。本综述仅考虑常规化合物和用于靶向治疗的小分子。

相似文献

1
Antineoplastic drugs and their analysis: a state of the art review.抗肿瘤药物及其分析:综述
Analyst. 2017 Jul 7;142(13):2273-2321. doi: 10.1039/c7an00367f. Epub 2017 May 31.
2
Analysis of anticancer drugs: a review.抗癌药物分析:综述。
Talanta. 2011 Oct 15;85(5):2265-89. doi: 10.1016/j.talanta.2011.08.034. Epub 2011 Aug 24.
3
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
4
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
5
Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.家庭成员通过接受治疗的癌症患者的排泄物接触抗肿瘤药物。
J Oncol Pharm Pract. 2013 Sep;19(3):208-17. doi: 10.1177/1078155212459667. Epub 2012 Oct 11.
6
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
7
Nanocarriers for cancer-targeted drug delivery.用于癌症靶向药物递送的纳米载体。
J Drug Target. 2016;24(3):179-91. doi: 10.3109/1061186X.2015.1051049. Epub 2015 Jun 10.
8
Adaptive control methods for the dose individualisation of anticancer agents.抗癌药物剂量个体化的自适应控制方法。
Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003.
9
Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics.细胞毒性抗癌药物与靶向癌症治疗药物的功能分化
Regul Toxicol Pharmacol. 2014 Oct;70(1):46-53. doi: 10.1016/j.yrtph.2014.06.012. Epub 2014 Jun 20.
10
MicroRNAs and cancer resistance: A new molecular plot.微小RNA与癌症抗性:一个新的分子情节。
Clin Pharmacol Ther. 2016 May;99(5):485-93. doi: 10.1002/cpt.353. Epub 2016 Mar 17.

引用本文的文献

1
Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia.用于慢性髓性白血病靶向治疗的抗癌药物电化学传感器。
ADMET DMPK. 2025 Jul 18;13(4):2825. doi: 10.5599/admet.2825. eCollection 2025.
2
Comparative analysis of dermal and inhalation exposures to antineoplastic drugs among workers in the workplaces: a systematic review.工作场所工人中抗肿瘤药物皮肤暴露与吸入暴露的比较分析:一项系统综述
BMC Public Health. 2025 May 15;25(1):1800. doi: 10.1186/s12889-024-21191-4.
3
Characterization of Pharmaceutical Transformation Products by High-Field Asymmetric Waveform Ion Mobility and Infrared Ion Spectroscopy Coupled to Mass Spectrometry.
通过高场非对称波形离子迁移率和红外离子光谱与质谱联用对药物转化产物进行表征
J Am Soc Mass Spectrom. 2025 Jun 4;36(6):1277-1285. doi: 10.1021/jasms.5c00039. Epub 2025 May 12.
4
Impact of Methotrexate and 7-Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non-Hodgkin Lymphoma.甲氨蝶呤和7-羟基甲氨蝶呤暴露对儿童非霍奇金淋巴瘤肾毒性的影响
Cancer Med. 2025 Jan;14(2):e70516. doi: 10.1002/cam4.70516.
5
Development and validation of an UPLC-ESI-MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure.一种用于意外暴露后同时定量测定人血浆中抗肿瘤药物及其代谢物的超高效液相色谱-电喷雾串联质谱法的开发与验证
Arch Toxicol. 2025 Jan;99(1):259-270. doi: 10.1007/s00204-024-03900-5. Epub 2024 Oct 31.
6
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer.lncRNAs 作为铜死亡介导的癌症的预后标志物和治疗靶点。
Clin Exp Med. 2024 Sep 26;24(1):226. doi: 10.1007/s10238-024-01491-0.
7
Research Progress on Flavonoids in Traditional Chinese Medicine to Counteract Cardiotoxicity Associated with Anti-Tumor Drugs.中药中黄酮类化合物对抗抗肿瘤药物心脏毒性的研究进展
Rev Cardiovasc Med. 2024 Feb 27;25(3):74. doi: 10.31083/j.rcm2503074. eCollection 2024 Mar.
8
Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies.甲氨蝶呤诱导的肠道损伤的分子机制及保护策略。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8165-8188. doi: 10.1007/s00210-024-03164-x. Epub 2024 Jun 1.
9
Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.米糠阿拉伯木聚糖复合物作为一种天然产物用于癌症治疗——对作用机制和效果的循证评估。
Pharm Biol. 2024 Dec;62(1):367-393. doi: 10.1080/13880209.2024.2349042. Epub 2024 May 15.
10
Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review.影响甲氨蝶呤药代动力学的因素凸显了个体化剂量调整的必要性:一项系统综述
Eur J Clin Pharmacol. 2024 Jan;80(1):11-37. doi: 10.1007/s00228-023-03579-0. Epub 2023 Nov 7.